Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Subscribe to Free Drug Patent Expiration Updates

Also available in a Drug Patent Expiration NewsletterRSS feed and on Drug Patent Expirations on TwitterTwitter

DrugPatentWatch Archives

You are currently viewing the 2011 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: 8-HOUR BAYER

« Back to Dashboard
8-hour Bayer is a drug marketed by Bayer and is included in one NDA.

The generic ingredient in 8-HOUR BAYER is aspirin. There are nineteen drug master file entries for this compound. Additional details are available on the aspirin profile page.

Summary for Tradename: 8-HOUR BAYER


Clinical Trials for: 8-HOUR BAYER

Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study
Status: Completed Condition: Erectile Dysfunction

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
Status: Completed Condition: Infectious Diseases

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
Status: Completed Condition: Abscess; Wound Infection; Diabetic Foot; Ulcer

Placebo Controlled, Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Tolerability of BAY58-2667
Status: Terminated Condition: Congestive Heart Failure

Drug-Eluting Balloon Catheters and the Treatment of Peripheral Arterial Occlusive Disease
Status: Completed Condition: Peripheral Arterial Disease; Stenotic Femoro-popliteal Arteries; Occluded Femoro-popliteal Arteries; Atherosclerosis

Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent
Status: Active, not recruiting Condition: Magnetic Resonance Imaging

Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery
Status: Completed Condition: Blood Loss, Surgical; Postoperative Hemorrhage

A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
Status: Recruiting Condition: Immune Thrombocytopenic Purpura

Naproxen Sodium/ASA Platelet Study
Status: Completed Condition: Pain

Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks
Status: Completed Condition: Erectile Dysfunction

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TABLET, EXTENDED RELEASE; ORAL016030-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn